Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy-Reference-Cited by-同舟云学术

Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy

Published:2019-12-15 Issue:12 Volume:11 Page:1172-1181
ISSN:1948-5204
Container-title:World Journal of Gastrointestinal Oncology
language:
Short-container-title:WJGO

Author:

Zeng Ya,Yu Wen,Liu Qi,Yu Wei-Wei,Zhu Zheng-Fei,Zhao Wei-Xin,Liu Jun,Wang Jia-Ming,Fu Xiao-Long,Liu Yuan,Cai Xu-Wei

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,Oncology

Reference25 articles.

1. Cancer statistics in China, 2015

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers, 2017. Available from: URL: https://www.nccn.org/professionals/physician_gls/default.aspx

3. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

4. Recurrence Pattern of Squamous Cell Carcinoma in the Middle Thoracic Esophagus after Modified Ivor-Lewis Esophagectomy

5. Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Treatment Strategies for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Triple Cohort Analysis Using Propensity Score Matching;International Journal of General Medicine;2023-11

2. Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer;Frontiers in Surgery;2022-09-02

3. Effect and safety of anlotinib combined with S-1 for recurrent or metastatic esophageal cancer patients who refused or were intolerant to intravenous chemotherapy;Medicine;2021-12-23

4. Correlates of Long-Term Survival of Patients with pN+ Esophageal Squamous Cell Carcinoma after Esophagectomy;Journal of Oncology;2021-02-17

5. Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma;BioMed Research International;2021-01-22